Valuation MedinCell LIQUIDNET SYSTEMS

Stocks

End-of-day quote LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

07-29	Teva raises its guidance for Uzedy, Medincell benefits
07-28	Medincell Announces Board Resignations	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	186.4	246.2	275.7	476.2	809.3	879.8	-	-
Change	-	32.11%	11.97%	72.7%	69.96%	8.72%	-	-
Enterprise Value (EV) ¹	209.3	294.4	318.1	468.9	794	865	849.3	768.4
Change	-	40.69%	8.03%	47.42%	69.34%	8.94%	-1.81%	-9.53%
P/E	-7.42x	-7.72x	-10.9x	-23.2x	-24x	408x	51.5x	15.8x
PBR	-13.9x	-5.86x	-6.68x	-26.1x	-	59.8x	10.9x	4.39x
PEG	-	-0.3x	0.4x	0.8x	-0.5x	-4x	0x	0x
Capitalization / Revenue	45.6x	24.9x	30.5x	18.7x	33.3x	19.9x	14.9x	8.93x
EV / Revenue	51.2x	29.8x	35.2x	18.4x	32.7x	19.6x	14.4x	7.8x
EV / EBITDA	-9.39x	-13.2x	-16.5x	-53x	-41.9x	126x	35.4x	12.1x
EV / EBIT	-8.79x	-12.3x	-15.2x	-43.6x	-38.3x	283x	30.4x	13x
EV / FCF	-9.1x	-13.4x	-24.3x	26.3x	-	-155x	61.5x	13.1x
FCF Yield	-11%	-7.48%	-4.12%	3.8%	-	-0.64%	1.63%	7.66%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1	-1.27	-0.88	-0.62	-0.94	0.06	0.476	1.548
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	4.091	9.889	9.032	25.42	24.28	44.14	58.92	98.52
EBITDA ¹	-22.3	-22.36	-19.26	-8.85	-18.96	6.875	24.01	63.58
EBIT ¹	-23.81	-24.02	-20.94	-10.76	-20.74	3.052	27.92	59.33
Net income ¹	-24.81	-29.5	-25.04	-18.44	-31.29	0.6667	13.33	47.18
Net Debt ¹	22.87	48.18	42.34	-7.296	-15.29	-14.87	-30.53	-111.4
Reference price ²	7.42	9.81	9.59	14.40	22.54	24.50	24.50	24.50
Nbr of stocks (in thousands)	25,121	25,101	28,749	33,066	35,904	35,912	-	-
Announcement Date	6/14/22	6/26/23	6/10/24	6/17/25	6/16/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.6x	12.29x	24.81x	0.58%	1,057B
JOHNSON & JOHNSON	28.84x	-	-	2.07%	625B
ABBVIE INC.	32.34x	7.35x	15.3x	2.81%	435B
ROCHE HOLDING AG	20.47x	4.85x	12.02x	2.72%	363B
NOVARTIS AG	22.14x	5.72x	14.28x	2.8%	296B
ASTRAZENECA PLC	20.58x	4.25x	12.07x	2.07%	249B
AMGEN INC.	25.76x	6.79x	12.06x	2.45%	222B
NOVO NORDISK A/S	13.84x	4.97x	10.44x	3.68%	209B
GILEAD SCIENCES, INC.	-41.38x	5.93x	33.46x	2.47%	165B
Average	17.35x	6.52x	16.80x	2.41%	402.31B
Weighted average by Cap.	24.44x	8.09x	18.31x	1.98%